MolecuLight introduces MolecuLight i:X, the first-ever wound assessment device to provide real-time imaging of bacteria distribution at the point-of-care.
http://www.moleculight.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
0.4 seconds
16x16
32x32
64x64
Miroslav Pendev
255 Glenl●●●●●●●●●Apt. 1401
To●●to , Ontario, M6P 1G2
Canada
View this contact
Miroslav Pendev
255 Glenl●●●●●●●●●Apt. 1401
To●●to , Ontario, M6P 1G2
Canada
View this contact
Miroslav Pendev
255 Glenl●●●●●●●●●Apt. 1401
To●●to , Ontario, M6P 1G2
Canada
View this contact
BUY YOUR DOMAIN
25
YEARS
1
MONTHS
0
DAYS
GODADDY.COM, LLC
WHOIS : whois.godaddy.com
REFERRED : http://registrar.godaddy.com
PAGES IN
THIS WEBSITE
4
SSL
EXTERNAL LINKS
3
SITE IP
54.204.24.232
LOAD TIME
0.391 sec
SCORE
6.2
MolecuLight | Imaging Device To Visualize Bacteria In Wounds | moleculight.com Reviews
https://moleculight.com
MolecuLight introduces MolecuLight i:X, the first-ever wound assessment device to provide real-time imaging of bacteria distribution at the point-of-care.
moleculight.com
MolecuLight Mission and Core Values
http://moleculight.com/about-us
MolecuLight i:X First-ever Wound Assessment Device. Fluorescence-Guided Wound Imaging Technology. MolecuLight strives to become the ubiquitous name in fluorescence-guided wound imaging technologies and to serve the healthcare industry with world-class products and services while delivering value to all customers, employees and shareholders. Operating in an ethical manner at all times. Improving patient outcomes through product innovation. Remaining focused on customer, employee, and shareholder needs.
NEWS | MolecuLight i:X First-ever Wound Assessment Device
http://moleculight.com/www.moleculight.com/news
MolecuLight i:X First-ever Wound Assessment Device. Fluorescence-Guided Wound Imaging Technology. The New Era of Point-of-care Testing. The March 2016 Issue of the Medical Post Magazine brings an article on The new era of point-of-care testing. The latest devices are very different … [Read More.]. Making The Invisible Visible: First-of-its-kind Medical Device Shines New Light on Chronic Wounds. Innovative Technology by MolecuLight Inc. Poised to Revolutionize Chronic Wound Care. The publication describes...
MolecuLight i:X | Wound Assessment Device
http://moleculight.com/product
MolecuLight i:X First-ever Wound Assessment Device. Fluorescence-Guided Wound Imaging Technology. MolecuLight’s first product, the. Easily integrates into hospital acute care environments. Instant Visualization of Bacteria. Intuitive, Simple to Use. Images/Videos Easily Appended to Patient's File. Wound Closure Acceleration with Fluorescence Guidance. Evaluation of Surgical Site Infections with Fluorescence Imaging. Sign-up for Our eNewsletter. The MolecuLight i:X Imaging Device is approved by Health Can...
NEWS | MolecuLight i:X First-ever Wound Assessment Device
http://moleculight.com/news
MolecuLight i:X First-ever Wound Assessment Device. Fluorescence-Guided Wound Imaging Technology. The New Era of Point-of-care Testing. The March 2016 Issue of the Medical Post Magazine brings an article on The new era of point-of-care testing. The latest devices are very different … [Read More.]. Making The Invisible Visible: First-of-its-kind Medical Device Shines New Light on Chronic Wounds. Innovative Technology by MolecuLight Inc. Poised to Revolutionize Chronic Wound Care. The publication describes...
TOTAL PAGES IN THIS WEBSITE
4
Home
http://www.ceso.on.ca/index.html
Tuesday, September 13, 2016. CESO 2017 Winter Conference. February 6 and 7, 2017. The Clinical Engineering Society of Ontario aims to unite the members of the Clinical Engineering and BMET professions, and encourage their professional development through our conference sessions on current topics and the educational seminars at the conference. To find out about our Facebook and. Twitter pages, as well as, our Yahoo! Please like us on Facebook, share your favorite moments, and tweet about.
TOTAL LINKS TO THIS WEBSITE
3
UNDER CONSTRUCTION
Is currently UNDER CONSTRUCTION. This Web site is currently under construction. Please be sure to visit this Web site again in the near future! This is your current default homepage; it has been setup with your new account. To update this Under Construction page, please replace your index.html file.
UNDER CONSTRUCTION
Is currently UNDER CONSTRUCTION. This Web site is currently under construction. Please be sure to visit this Web site again in the near future! This is your current default homepage; it has been setup with your new account. To update this Under Construction page, please replace your index.html file.
moleculia-walks-the-walk.blogspot.com
Moleculia Walks the Walk
Moleculia Walks the Walk. Monday, January 10, 2011. 3 new Australian Terrier videos are added today. Click here to go to the page. Links to this post. Tuesday, December 28, 2010. Talking about REACH AND DRIVE! Click the picture to go to the movie! Links to this post. Oelmuhle, adult female on the move. An other nice movie of an adult female on the move at Oelmuhle. Click here to see the movie. Links to this post. Sunday, December 26, 2010. Links to this post. Links to this post. New Section, Fun videos.
Home
Moleculia Walks the Walk. 2010 henny Contact Me. Moleculia Walks the Walk. Movement - the act of moving. Movement is a measure of a dog's conformation. But how is a specific breed supposed to move? The standard tells us what the movement should be, but many times the standard is misinterpreted. The only way to determen correct movement is to evaluate movement. How? By looking at it.
Home
Moleculia Walks the Walk. 2010 henny Contact Me. Moleculia Walks the Walk. Movement - the act of moving. Movement is a measure of a dog's conformation. But how is a specific breed supposed to move? The standard tells us what the movement should be, but many times the standard is misinterpreted. The only way to determen correct movement is to evaluate movement. How? By looking at it.
MolecuLight | Imaging Device To Visualize Bacteria In Wounds
8211; Main Menu –. The invisible is now visible. Empowering clinicians with information. Impacting patient lives at the point-of-care. MolecuLight is developing a handheld optical imaging technology to visualize bacteria in real-time at the point of care. The device will provide real-time bacteriological information which is otherwise unobtainable using industry standard wound assessment techniques, including conventional white light visualization. See the latest scientific updates.
Moleculin Biotech - Moleculin Biotech, Inc. is a pre-clinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Eac
Moleculin Biotech, Inc. is a pre-clinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology. Annamycin vs. Daunorubicin. Management & Business Advisors. Partnerships & Collaborations. Better Target, Better Outcomes:. Advancing breakthrough therapeutic approaches to cancer.
Moleculinair.net | Uw online winkel voor moleculair koken
Ldquo; Uw online winkel voor moleculair koken ”. Met trots heten we u welkom op de website van moleculinair.net. Gepubliceerd op dinsdag 11 augustus 2015. Dit is een test nieuws bericht met een plaatje. Lees verder ». Office 309 / Tijs.
The domain name is registered
THE DOMAIN NAME IS REGISTERED. DOMÉNA JE ZAREGISTROVÁNA. A DOMAIN NÉV REGISZTRÁLT.
My Site
This is my site description. A website created by GoDaddy’s Website Builder.
www.moleculis.org
SOCIAL ENGAGEMENT